Application of nucleoside analogues to liver transplant recipients with hepatitis B

doi:10.3748/wjg.v21.i42.12091

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8084)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

650

WORD

393

HTML

4334

Tables (1-3)

255

Sum=5632

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1080

Download

1372

Sum=2452

Nov 14, 2015 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 14, 2015; 21(42): 12091-12100
Published online Nov 14, 2015. doi: 10.3748/wjg.v21.i42.12091

Table 2 Treatment selections for liver transplant recipients with HBV recurrence and drug resistance[10,16,84]

HBV recurrence after liver transplant	LAM resistance	Add ADV or switch to ETV or TDF
	ADV resistance	Switch to TDF
	ETV resistance	Switch to TDF
	HBIG resistance	Switch to NAs monotherapy or combined therapy

HBV: Hepatitis B virus; LAM: Lamivudine; ADV: Adefovir dipivoxil; ETV: Entecavir; TDF: Tenofovir; HBIG: Hepatitis B immune globulin; NA: Nucleoside analogue.

Citation: Song ZL, Cui YJ, Zheng WP, Teng DH, Zheng H. Application of nucleoside analogues to liver transplant recipients with hepatitis B. World J Gastroenterol 2015; 21(42): 12091-12100
URL: https://www.wjgnet.com/1007-9327/full/v21/i42/12091.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i42.12091